Product
Platform
Drug Modules
Integrations
TeamCareersInsightsNews & EventsRequest trial

Press Releases

AllPress ReleasesIn the NewsInsightsEventsLearning Lounge
Blog

Understanding FDA’s Perspective on Precision Dosing

Press Release

InsightRX Reports Record Growth in Platform Adoption by Health Systems and Biopharma Companies

Press Release

InsightRX Selected for Inaugural Cohort in Cutting-Edge Innovation Hub to Transform Cancer Care

Press Release

Saladax Biomedical and InsightRX to Present Chemotherapy Drug Outcomes at International Congress in September

Press Release

InsightRX Receives CE Mark for Nova Software, Allowing it to Expand Precision Dosing Capabilities in Europe

Press Release

Hospital precision dosing is ramping up

Press Release

InsightRX’s Precision Medicine Platform Integrated into Sentara Healthcare EHR to Help Safely Administer Vancomycin Doses for Treatment of Infections

Press Release

InsightRX Adds Renowned Pharmacology Experts Drs. Richard Peck and Michael Rybak to its Scientific Advisory Board

Press Release

New Study Co-Authored by InsightRX Shows Model-Informed Precision Dosing Could Improve Efficacy of Hematopoietic Cell Transplants While Reducing Toxicity

Press Release

‍Pharmacy and Healthcare Professionals Nationwide Recognize Patient Safety Benefits of New Consensus Vancomycin Dosing Guidelines, But Fewer than One in Three Plan to Adopt Them

Press Release

InsightRX Named Finalist in Accenture's HealthTech Innovation Challenge

Press Release

InsightRX and Premier Inc. Partner to Enable Hospitals, Health Systems and Providers to Individualize Treatment for Infectious Disease Patients

Press Release

Healthcare Technology Startup InsightRX Raises $10 Million to Enable Precision Dosing at Point of Care

Press Release

InsightRX and Children's Hospital Los Angeles (CHLA) to Partner on Precision Dosing

Interested in trying the InsightRX Platform?
Contact us for a free trial.
Contact Us
PRODUCT
  • Platform
  • Drug Modules
  • Integrations
company
  • Team
  • Careers
  • News
Resources
  • Privacy Policy
  • Contact Us
InsightRX Nova and InsightRX Apollo are not considered to be medical devices in the U.S. and have not been submitted to the U.S. Food and Drug Administration for review or clearance.
Copyright © 2021 InsightRX, Inc. 740-05000-REC-01 02/2021